Literature DB >> 14512080

Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells.

Steffen Massberg1, Felix Vogt, Timm Dickfeld, Korbinian Brand, Sharon Page, Meinrad Gawaz.   

Abstract

OBJECTIVE: Exposure of the subendothelium to flowing blood following rupture of atherosclerotic lesions or during balloon angioplasty initiates platelet adhesion to the vascular wall. Because activated platelets release proinflammatory mediators (e.g., interleukin (IL)-1beta) and secrete growth factors, platelet adhesion to the subendothelial matrix might contribute to the recruitment of inflammatory cells and promote migration and proliferation of vascular smooth muscle cells (SMCs). METHODS AND
RESULTS: Here, we demonstrate that incubation of cultured monolayers of aortic SMCs with alpha-thrombin-activated platelets significantly enhances the secretion of monocyte chemoattractant protein-1 (MCP-1) (P<0.05) and promotes SMC migration (P<0.05). Platelet-induced secretion of MCP-1 was abolished by anti-IL-1alpha and beta monoclonal antibodies or the IL-1 receptor antagonist (IL-1RA). In contrast, platelet-mediated SMC migration was attenuated only by anti-platelet-derived growth factor (PDGF)-mAb but not by IL-1RA. Correspondingly, recombinant human interleukin-1 (rhIL-1) beta increased MCP release by SMCs but had no effect on SMC migration. Platelet-mediated MCP secretion by SMCs involved the activation and nuclear translocation of the transcription factor nuclear factor-kappaB (NF-kappaB).
CONCLUSION: Therefore, platelet adhesion to the subendothelium increases the chemotactic and migratory properties of SMC and is likely to contribute substantially to the process of atherosclerosis and vessel (re-)stenosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512080     DOI: 10.1016/s0049-3848(03)00342-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  16 in total

1.  Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms.

Authors:  Matthew R Alexander; Meera Murgai; Christopher W Moehle; Gary K Owens
Journal:  Physiol Genomics       Date:  2012-02-07       Impact factor: 3.107

2.  Inflammation and platelet activation in peripheral arterial occlusive disease.

Authors:  Martina Montagnana; Cristiano Fava; Enrico Arosio; Maurizio Degan; Rosa Maria Tommasoli; Sergio De Marchi; Pietro Delva; Roberta Spadaro; Gian Cesare Guidi; Alessandro Lechi; Clara Lechi Santonastaso; Pietro Minuz
Journal:  Int J Angiol       Date:  2007

3.  Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury.

Authors:  Raimo Tuuminen; Annukka Jouppila; Dan Salvail; Charles-E Laurent; Marie-Claude Benoit; Simo Syrjälä; Heikki Helin; Karl Lemström; Riitta Lassila
Journal:  Clin Exp Nephrol       Date:  2016-07-12       Impact factor: 2.801

4.  Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets.

Authors:  Katrin Anne Becker; Nadine Beckmann; Constantin Adams; Gabriele Hessler; Melanie Kramer; Erich Gulbins; Alexander Carpinteiro
Journal:  Clin Exp Metastasis       Date:  2016-10-15       Impact factor: 5.150

Review 5.  Thrombin and vascular inflammation.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  Mol Cell Biochem       Date:  2011-08-23       Impact factor: 3.396

6.  Effect of serotonin on the differentiation of human monocytes into dendritic cells.

Authors:  N Katoh; F Soga; T Nara; R Tamagawa-Mineoka; M Nin; H Kotani; K Masuda; S Kishimoto
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis.

Authors:  Dirk Lievens; Alma Zernecke; Tom Seijkens; Oliver Soehnlein; Linda Beckers; Imke C A Munnix; Erwin Wijnands; Pieter Goossens; Roger van Kruchten; Larissa Thevissen; Louis Boon; Richard A Flavell; Randolph J Noelle; Norbert Gerdes; Erik A Biessen; Mat J A P Daemen; Johan W M Heemskerk; Christian Weber; Esther Lutgens
Journal:  Blood       Date:  2010-08-12       Impact factor: 22.113

8.  The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.

Authors:  Gianluca Grassia; Marcella Maddaluno; Angelo Guglielmotti; Giorgina Mangano; Giuseppe Biondi; Pasquale Maffia; Armando Ialenti
Journal:  Cardiovasc Res       Date:  2009-07-10       Impact factor: 10.787

Review 9.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

10.  The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats.

Authors:  A Schäfer; J Pfrang; J Neumüller; S Fiedler; G Ertl; J Bauersachs
Journal:  Br J Pharmacol       Date:  2008-05-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.